Authsnap, Inc.
Pilot Study Participation Opportunity – Denial Management Technology
Introduction
Authsnap, Inc. (“Authsnap”), a Delaware corporation, invites qualified healthcare organizations to participate in a time-limited pilot study evaluating the performance of Authsnap’s AI-powered denial management platform.
The pilot is designed to assess clinical and financial outcomes associated with denial pattern identification, automated appeal generation, and revenue recovery. Participation will be at no cost to the organization during the defined pilot period. The program is supported in part by the Michigan Business Accelerator Fund; however, participation is open to eligible facilities nationwide. Authsnap has raised $400,000 of seed funding to date and is supported by Michigan Rise in partnership with MSU Research Foundation and Michigan Economic Development Corporation (MEDC) as well as Biosciences Research and Commercialization Center of Western Michigan University as well as Innovate Marquette SmartZone.
Eligibility Criteria
To be considered, organizations must meet the following minimum requirements:
Claim Denial Volume – Minimum of 100 denials per month in identifiable clusters or recurring patterns (e.g., outpatient procedure denials, inpatient denials, or DRG downgrades).
Claim Denial Size – Average denied claim value of $1,500 or greater.
Data Access – Participant must either (a) provide read-only access to its electronic medical record (EMR) system, or (b) securely upload relevant denial/claims data to Authsnap’s portal.
Organizational Readiness – Willingness to designate a point of contact to coordinate data exchange, participate in periodic status reviews, and assist in validating results.
Pilot Design and Duration
Term: Ninety (90) consecutive days from commencement.
Scope: Limited to denial categories jointly selected by Authsnap and the Participant at initiation of the study.
Deliverables: At the conclusion of the Pilot Period, Authsnap will provide a written report summarizing appeal outcomes, revenue recovery, and operational efficiency metrics.
Cost / Consideration
Participant shall receive the pilot services at no charge for the Pilot Period.
Participation does not create any obligation on the part of Participant to purchase services from Authsnap following the Pilot Period.
The pilot is intended solely as a time-limited evaluation.
Compliance Representations
This opportunity does not require, and is not conditioned upon, the referral of patients or business to Authsnap or any affiliated entity.
No remuneration is offered or intended in exchange for referrals.
The arrangement is structured to be consistent with applicable federal and state laws, including, without limitation, the Physician Self-Referral Law (Stark Law) and the Physician Payments Sunshine Act (Open Payments Program).
All data transfers will be governed by a Business Associate Agreement (BAA) and, if applicable, a Data Use Agreement (DUA).
Participation is subject to execution of a Pilot Participation Agreement between the parties.
Submissions should be directed to:
Questions: info@authsnap.ai
651-217-8193
About Authsnap
Authsnap is a healthcare technology company focused on transforming denial management through automation and clinical intelligence. Founded by healthcare and technology professionals with extensive utilization management experience, Authsnap is committed to reducing administrative waste, supporting provider financial sustainability, and enabling greater focus on patient care.